Page 311 - ATP-P 11th Ed
P. 311
• Pain at injection site
• Nausea and vomiting
Adverse reactions:
• Bradycardia
• CV collapse
• Amnesia
• Abdominal discomfort
TMEP use:
• Back Pain Protocol
• Behavioral Changes Protocol
• Heat Illness Protocol
• K9 RDX (C-4) Ingestion Protocol
• Seizure Protocol
TTP use: Head injury induced seizures
®
Diflucan – See Fluconazole
®
Diphenhydramine HCl (Benadryl ) SECTION 3
GROUNDING medication for personnel on flight status
Description: Antihistamine. Prevents (but does not reverse) histamine-mediated responses.
H1 blocker
Indications:
• Mild to moderate allergic symptoms and/or allergic reactions
• Dystonic reaction
Adult dose: 25–50mg IM/IV/PO q6hr; max dose 400mg/day
Pediatric dose: Children <12 years: 5mg/kg/day in divided doses qid PO/IM/IV
K9 Dose: 1–2 mg/kg SC, IM, or PO (capsules)
Contraindications:
• Asthma
• Pregnant or lactating females
Pregnancy Category C
Side-effects:
• Sedation
• Blurred vision
• Nausea
• Vomiting
• Diarrhea
• Headache
Adverse reactions:
• Insomnia
ATP-P Handbook 11th Edition 301

